The Discounted Cash Flow (DCF) valuation of Vistin Pharma ASA (VISTN.OL) is 30.03 NOK. With the latest stock price at 21.90 NOK, the upside of Vistin Pharma ASA based on DCF is 37.1%.
Based on the latest price of 21.90 NOK and our DCF valuation, Vistin Pharma ASA (VISTN.OL) is a buy. buying VISTN.OL stocks now will result in a potential gain of 37.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.3% | 6.3% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 24.05 - 40.45 | 30.03 |
| Upside | 9.8% - 84.7% | 37.1% |